(2R,3R,4S,5S,6R)-2-(2-(3-benzyl-2,3-dihydro-1H-benzo[d]imidazol-1-yl)ethoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

ID: ALA5287059

Max Phase: Preclinical

Molecular Formula: C22H28N2O6

Molecular Weight: 416.47

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  OC[C@H]1O[C@@H](OCCN2CN(Cc3ccccc3)c3ccccc32)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C22H28N2O6/c25-13-18-19(26)20(27)21(28)22(30-18)29-11-10-23-14-24(12-15-6-2-1-3-7-15)17-9-5-4-8-16(17)23/h1-9,18-22,25-28H,10-14H2/t18-,19-,20+,21-,22-/m1/s1

Standard InChI Key:  YRAXQDBZLUSJNH-QMCAAQAGSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    4.3955   -1.9044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5705   -1.9044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1560   -1.1865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5690   -0.4724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3920   -0.4724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8049   -1.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3305   -1.1865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9177   -0.4715    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0933   -0.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9147    0.4220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6296    0.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8150    1.6539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6196    1.9044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2367    1.3371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0564    0.5147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2486    0.2632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1998    0.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5150    0.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2299    0.8347    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9448    0.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9448   -0.4037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2299   -0.8165    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6599   -0.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6599   -1.6421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3750   -0.4037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0899   -0.8165    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3750    0.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0899    0.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8049    0.4220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6599    0.8349    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  7  3  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 11 12  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 16  8  1  0
 11 16  2  0
 17 10  1  0
 18 17  1  0
 19 18  1  0
 20 19  1  1
 21 20  1  0
 21 22  1  6
 23 21  1  0
 23 24  1  1
 25 23  1  0
 25 26  1  6
 27 25  1  0
 27 28  1  1
 28 29  1  0
 27 30  1  0
 20 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287059

    ---

Associated Targets(non-human)

BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.47Molecular Weight (Monoisotopic): 416.1947AlogP: 0.29#Rotatable Bonds: 7
Polar Surface Area: 105.86Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.21CX Basic pKa: CX LogP: 1.39CX LogD: 1.39
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.51Np Likeness Score: 0.65

References

1. Lopes JPB, Silva L, Lüdtke DS..  (2021)  An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases.,  12  (12.0): [PMID:35028560] [10.1039/D1MD00217A]

Source